Huasheng International Holding Limited (1323.HK)

HKD 0.24

(0.0%)

EBITDA Summary of Huasheng International Holding Limited

Huasheng International Holding Limited's latest annual EBITDA in 2023 was 19.67 Million HKD , down -2.52% from previous year.
Huasheng International Holding Limited's latest quarterly EBITDA in 2023 FY was N/A , down -2.52% from previous quarter.
Huasheng International Holding Limited reported an annual EBITDA of -1.59 Million HKD in 2022, down -61.92% from previous year.
Huasheng International Holding Limited reported an annual EBITDA of 82.69 Million HKD in 2021, down -1.15% from previous year.
Huasheng International Holding Limited reported a quarterly EBITDA of N/A for 2023 FY, down -2.52% from previous quarter.
Huasheng International Holding Limited reported a quarterly EBITDA of 27.53 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Huasheng International Holding Limited (2023 - 2009)

Historical Annual EBITDA of Huasheng International Holding Limited (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	19.67 Million HKD	-2.52%
2022	-1.59 Million HKD	-61.92%
2021	82.69 Million HKD	-1.15%
2020	75.85 Million HKD	9776.95%
2019	-30.53 Million HKD	-93.34%
2018	11.52 Million HKD	129.54%
2017	-45.89 Million HKD	10.07%
2016	-128.89 Million HKD	-1.52%
2015	-258.24 Million HKD	54.44%
2014	-153.43 Million HKD	-94.53%
2013	-130.2 Million HKD	-379.56%
2012	-19.18 Million HKD	400.58%
2011	-5.73 Million HKD	-108.67%
2010	66.15 Million HKD	-22.62%
2009	85.48 Million HKD	0.0%

Year	EBITDA	EBITDA Growth
2023 Q4	19.59 Million HKD	0.0%
2023 FY	- HKD	-2.52%
2023 Q2	27.53 Million HKD	0.0%
2022 Q4	26.39 Million HKD	0.0%
2022 Q2	2.16 Million HKD	0.0%
2022 FY	- HKD	-61.92%
2021 Q2	36.7 Million HKD	0.0%
2021 FY	- HKD	-1.15%
2021 Q4	45.29 Million HKD	0.0%
2020 Q4	34.04 Million HKD	0.0%
2020 Q2	41.8 Million HKD	0.0%
2020 FY	- HKD	9776.95%
2019 FY	- HKD	-93.34%
2019 Q2	40.12 Million HKD	0.0%
2019 Q4	-28.12 Million HKD	0.0%
2018 Q2	8.67 Million HKD	0.0%
2018 FY	- HKD	129.54%
2018 Q4	2.85 Million HKD	0.0%
2017 Q2	-4.52 Million HKD	0.0%
2017 FY	- HKD	10.07%
2016 FY	- HKD	-1.52%
2016 Q2	-26.29 Million HKD	0.0%
2015 FY	- HKD	54.44%
2015 Q2	-26.81 Million HKD	0.0%
2014 Q2	-52.41 Million HKD	0.0%
2014 FY	- HKD	-94.53%
2013 Q4	-18 Million HKD	0.0%
2013 Q2	-30.21 Million HKD	0.0%
2013 FY	- HKD	-379.56%
2012 Q4	-12.6 Million HKD	-395.52%
2012 FY	- HKD	400.58%
2012 Q1	-1.04 Million HKD	0.0%
2012 Q2	-1.04 Million HKD	0.0%
2012 Q3	4.26 Million HKD	508.82%
2011 Q4	-1.04 Million HKD	0.0%
2011 Q2	16.53 Million HKD	0.0%
2011 Q1	16.53 Million HKD	0.0%
2011 FY	- HKD	-108.67%
2011 Q3	-1.04 Million HKD	-106.31%
2010 Q3	16.53 Million HKD	-22.62%
2010 Q2	21.37 Million HKD	0.0%
2010 FY	- HKD	-22.62%
2010 Q1	21.37 Million HKD	0.0%
2010 Q4	16.53 Million HKD	0.0%
2009 Q4	21.37 Million HKD	0.0%
2009 FY	- HKD	0.0%
2009 Q3	21.37 Million HKD	0.0%

Peer EBITDA Comparison of Huasheng International Holding Limited

Name	EBITDA	EBITDA Difference
Natural Beauty Bio-Technology Limited	22.91 Million HKD	14.115%
Innovative Pharmaceutical Biotech Limited	317.74 Million HKD	93.807%
China Overseas Nuoxin International Holdings Limited	2.02 Million HKD	-869.837%
Prosperous Future Holdings Limited	-19.68 Million HKD	199.959%
Fourace Industries Group Holdings Limited	61.52 Million HKD	68.016%
Evergreen Products Group Limited	140.78 Million HKD	86.022%
EC Healthcare	737.83 Million HKD	97.333%
Ming Fai International Holdings Limited	211.83 Million HKD	90.711%
Blue Moon Group Holdings Limited	656.37 Million HKD	97.002%
SuperRobotics Holdings Limited	-7.39 Million HKD	365.955%
Takbo Group Holdings Limited	25.8 Million HKD	23.741%
Hyfusin Group Holdings Limited	154.18 Million HKD	87.238%